Patent Assignment
Reel/Frame 021985/0419
Full Release of Collateral Assignment
Recorded: 2008-11-18
Pages: 4
Assignor
Assignee
SANOFI-AVENTIS U.S. LLC, SUCCESSOR TO BOCK PHARMACAL CO
55 CORPORATE DRIVE, BRIDGEWATER, NEW JERSEY, 08807
Covered Properties
(3)
Process for the Preparation of 2,3-Dimercaptosuccinic Acid and Its Lower Alkyl Esters
Patent:
4,550,193 →
Application:
06/385,953 →
Method for the Preparation of Low Odor 2,3-Dimercaptosuccinic Acid
Patent:
5,292,943 →
Application:
07/824,640 →
Use of Dimercaptan Acids, Salts and Metabolites Thereof as Antiretroviral Treatments
Patent:
5,464,869 →
Application:
08/380,787 →
Related Assignments
(11)
Other recorded transfers of the patents in this record — the chain of ownership.
Security Interest
Aug 12, 2003
From: OVATION PHARMACEUTICALS, INC.
To: LASALLE BANK NATIONAL ASSOCIATION
Reel/Frame 014373/0445 →
Assignment of Assignor's Interest
Sep 8, 2003
From: SANOFI-SYNTHELABO INC.
To: OVATION PHARMACEUTICALS, INC.
Reel/Frame 014546/0178 →
Assignment of Assignor's Interest
Oct 27, 2003
From: SANOFI-SYNTHELABO INC.
To: OVATION PHARMACEUTICALS, INC.
Reel/Frame 014634/0171 →
Security Agreement
Aug 18, 2005
From: OVATION PHARMACEUTICALS, INC.
To: MERRILL LYNCH CAPITAL, A DIVISION OF MERRILL LYNCH BUSINESS FINANCIAL SERVICES, INC.
Reel/Frame 016418/0175 →
Assignment of Assignor's Interest
May 3, 2006
From: SANOFI-SYNTHELABO INC.
To: SANOFI-AVENTIS U.S. LLC
Reel/Frame 017564/0129 →
Security Agreement
Dec 26, 2006
From: OVATION PHARMACEUTICALS, INC.
To: MERRILL LYNCH CAPITAL, A DIVISION OF MERRILL LYNCH BUSINESS FINANCIAL SERVICES, INC.
Reel/Frame 018679/0933 →
Release of Security Interest
Sep 26, 2007
From: LASALLE BANK NATIONAL ASSOCIATION
To: OVATION PHARMACEUTICALS, INC.
Reel/Frame 019881/0358 →
Assignment of Assignor's Interest
Feb 13, 2008
From: TRAVERS, JOHN D.; HELZNER, EILEEN C.
To: MCNEIL-PPC, INC.
Reel/Frame 020497/0664 →
Assignment of Assignor's Interest
Feb 26, 2008
From: SANOFI-AVENTIS U.S. LLC
To: OVATION PHARMACEUTICALS, INC.
Reel/Frame 020555/0257 →
Release of Security Interest
Mar 19, 2009
From: GE BUSINESS FINANCIAL SERVICES INC. FORMERLY KNOWN AS MERRILL LYNCH CAPITAL, A DIVISION OF MERRILL LYNCH BUSINESS FINANCIAL SERVICES INC.
To: OVATION PHARMACEUTICALS, INC.
Reel/Frame 022416/0565 →
Change of Name
Sep 1, 2009
From: OVATION PHARMACEUTICALS, INC
To: LUNDBECK INC.
Reel/Frame 023163/0805 →